212 related articles for article (PubMed ID: 37324507)
1. Early metabolic alterations in the normal‑appearing grey and white matter of patients with clinically isolated syndrome suggestive of multiple sclerosis: A proton MR spectroscopic study.
Tzanetakos D; Kyrozis A; Karavasilis E; Velonakis G; Tzartos JS; Toulas P; Sotirli SA; Evdokimidis I; Tsivgoulis G; Potagas C; Kilidireas C; Andreadou E
Exp Ther Med; 2023 Jul; 26(1):349. PubMed ID: 37324507
[TBL] [Abstract][Full Text] [Related]
2. Multi-voxel magnetic resonance spectroscopy of cerebral metabolites in healthy adults at 3 Tesla.
Doelken MT; Mennecke A; Stadlbauer A; Kloska S; Struffert T; Engelhorn T; Thuerauf N; Doerfler A; Stefan H; Hammen T
Acad Radiol; 2009 Dec; 16(12):1493-501. PubMed ID: 19781961
[TBL] [Abstract][Full Text] [Related]
3. Altered hypothalamic metabolism in early multiple sclerosis - MR spectroscopy study.
Hnilicová P; Kantorová E; Poláček H; Grendár M; Bittšanský M; Čierny D; Sivák Š; Zeleňák K; Lehotský J; Dobrota D; Kurča E
J Neurol Sci; 2019 Dec; 407():116458. PubMed ID: 31622679
[TBL] [Abstract][Full Text] [Related]
4. Neurometabolic timecourse of healthy aging.
Gong T; Hui SCN; Zöllner HJ; Britton M; Song Y; Chen Y; Gudmundson AT; Hupfeld KE; Davies-Jenkins CW; Murali-Manohar S; Porges EC; Oeltzschner G; Chen W; Wang G; Edden RAE
Neuroimage; 2022 Dec; 264():119740. PubMed ID: 36356822
[TBL] [Abstract][Full Text] [Related]
5. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.
Chard DT; Griffin CM; McLean MA; Kapeller P; Kapoor R; Thompson AJ; Miller DH
Brain; 2002 Oct; 125(Pt 10):2342-52. PubMed ID: 12244090
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
John NA; Solanky BS; De Angelis F; Parker RA; Weir CJ; Stutters J; Carrasco FP; Schneider T; Doshi A; Calvi A; Williams T; Plantone D; Monteverdi A; MacManus D; Marshall I; Barkhof F; Gandini Wheeler-Kingshott CAM; Chataway J;
J Magn Reson Imaging; 2024 Jun; 59(6):2192-2201. PubMed ID: 37787109
[TBL] [Abstract][Full Text] [Related]
7. Regional Myo-Inositol, Creatine, and Choline Levels Are Higher at Older Age and Scale Negatively with Visuospatial Working Memory: A Cross-Sectional Proton MR Spectroscopy Study at 7 Tesla on Normal Cognitive Ageing.
Lind A; Boraxbekk CJ; Petersen ET; Paulson OB; Siebner HR; Marsman A
J Neurosci; 2020 Oct; 40(42):8149-8159. PubMed ID: 32994337
[TBL] [Abstract][Full Text] [Related]
8. Positivity of oligoclonal bands in the cerebrospinal fluid predisposed to metabolic changes and rearrangement of inhibitory/excitatory neurotransmitters in subcortical brain structures in multiple sclerosis.
Kantorová E; Hnilicová P; Bogner W; Grendár M; Čierny D; Hečková E; Strasser B; Ružinák R; Zeleňák K; Kurča E
Mult Scler Relat Disord; 2021 Jul; 52():102978. PubMed ID: 34015640
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical differences in core regions of the autistic brain: a multivoxel
Dionísio A; Espírito A; Pereira AC; Mouga S; d'Almeida OC; Oliveira G; Castelo-Branco M
Sci Rep; 2024 Jan; 14(1):2374. PubMed ID: 38287121
[TBL] [Abstract][Full Text] [Related]
10. Case control study: magnetic resonance spectroscopy of brain in HIV infected patients.
Bairwa D; Kumar V; Vyas S; Das BK; Srivastava AK; Pandey RM; Sharma SK; Jagannathan NR; Sinha S
BMC Neurol; 2016 Jul; 16():99. PubMed ID: 27405321
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive performance in relapsing-remitting multiple sclerosis patients is associated with metabolic abnormalities of the thalamus but not the hippocampus- GABA-edited 1H MRS study.
Kantorová E; Hnilicová P; Bogner W; Grendár M; Grossmann J; Kováčová S; Hečková E; Strasser B; Čierny D; Zeleňák K; Kurča E
Neurol Res; 2022 Jan; 44(1):57-64. PubMed ID: 34313578
[TBL] [Abstract][Full Text] [Related]
12. Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high-field magnetic resonance spectroscopy.
Wattjes MP; Harzheim M; Lutterbey GG; Klotz L; Schild HH; Träber F
AJNR Am J Neuroradiol; 2007 Sep; 28(8):1517-22. PubMed ID: 17846203
[TBL] [Abstract][Full Text] [Related]
13. Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.
Tisell A; Leinhard OD; Warntjes JB; Aalto A; Smedby Ö; Landtblom AM; Lundberg P
PLoS One; 2013; 8(4):e61817. PubMed ID: 23613944
[TBL] [Abstract][Full Text] [Related]
14. High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria.
Wattjes MP; Harzheim M; Lutterbey GG; Bogdanow M; Schild HH; Träber F
J Neurol; 2008 Jan; 255(1):56-63. PubMed ID: 18080854
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance spectroscopy as marker for neurodegeneration in X-linked adrenoleukodystrophy.
van de Stadt SIW; Schrantee A; Huffnagel IC; van Ballegoij WJC; Caan MWA; Pouwels PJW; Engelen M
Neuroimage Clin; 2021; 32():102793. PubMed ID: 34461432
[TBL] [Abstract][Full Text] [Related]
16. Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans.
White TL; Monnig MA; Walsh EG; Nitenson AZ; Harris AD; Cohen RA; Porges EC; Woods AJ; Lamb DG; Boyd CA; Fekir S
Neuropsychopharmacology; 2018 Jun; 43(7):1498-1509. PubMed ID: 29511334
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of brain metabolite differences in HIV infection.
Chelala L; O'Connor EE; Barker PB; Zeffiro TA
Neuroimage Clin; 2020; 28():102436. PubMed ID: 33383609
[TBL] [Abstract][Full Text] [Related]
18. Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.
Tiberio M; Chard DT; Altmann DR; Davies G; Griffin CM; McLean MA; Rashid W; Sastre-Garriga J; Thompson AJ; Miller DH
J Neurol; 2006 Feb; 253(2):224-30. PubMed ID: 16307201
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis.
Wattjes MP; Harzheim M; Lutterbey GG; Bogdanow M; Schmidt S; Schild HH; Träber F
Neuroradiology; 2008 Feb; 50(2):123-9. PubMed ID: 17982745
[TBL] [Abstract][Full Text] [Related]
20. Longer Repetition Time Proton MR Spectroscopy Shows Increasing Hippocampal and Parahippocampal Metabolite Concentrations with Aging.
Sporn L; MacMillan EL; Ge R; Greenway K; Vila-Rodriguez F; Laule C
J Neuroimaging; 2019 Sep; 29(5):592-597. PubMed ID: 31273871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
